Antineuroinflammatory Effects of Modified Wu-Zi-Yan-Zong Prescription in β-Amyloid-Stimulated BV2 Microglia via the NF-κB and ERK/p38 MAPK Signaling Pathways

Table 2

HPLC analysis of modified Wu-Zi-Yan-Zong prescription (MWP). Characterization of compounds in MWP by HPLC analysis. Eb: Epimedium brevicornum Maxim.; Rc: Rubus chingii Hu; PA: Plantago asiatica L.; CC: Cuscuta chinensis Lam.; LB: Lycium barbarum L.; SC: Schisandra chinensis (Turcz.) Baill.

Number	Rt (min)	Identification	Constituent herbs
			Eb	Rc	PA	SC	CC	LB
1	4.5	L-Glycero-O-galactoheptitol-3,6-anhydro-O-glucoside			+
2	5.3	2-α-Nigerosylglucose						+
3	7.4	L-Ascorbic acid-O-glucoside			+
4	18.5	Guanosine			+			+
5	38.9	Quinic acid-O-caffeoyl-O-glucoside			+
6	41.5	Chlorogenic acid			+
7	44.5	Quinic acid-O-caffeoyl-O-glucoside			+
8	44.9	Limocitrol-O-glucoside	+
9	46.2	Cinnamoylquinic acid			+
10	51.2	Caffeoylquinic acid			+
11	51.5	Caffeoylquinic acid			+
12	55.5	Benzenepropanamide,N-[3-[[4-[(3-aminopropyl)amino] butyl]amino]^−propyl]-3,4-dihydroxy						+
13	58.2	Cinnamoylquinic acid			+
14	61.9	Kaempferol-di-O-glucoside	+	+	+		+	+
15	62.4	Quinic acid-tri-O-glucoside			+
16	67.8	Quercetin-O-glucosyl-O-xyloside	+	+	+		+	+
17	81.6	Desmethylicaritin-O-rhamnosyl-O-glucoside	+
18	82.1	Epimedoside E	+
19	85.4	Hydroxyisocupressoside B				+	+	+
20	87.2	Sagittasine C	+
21	87.9	Icariine	+
22	88.6	Epimedin B	+
23	89.5	Icaritin-O-rhamonosyl-O-rutinoside	+
24	90.9	Epimediside A	+
25	92.9	8-Dihydroprenylquercetin-O-methyl-tri-O-acetyl-O-rutinoside	+
26	93.5	8-Dihydroprenylquercetin-di-O-cinnamoyl-O-glucoside	+
27	99.2	Epimedin K	+
28	100.2	Icaritin-tri-O-methyl-O-rutinoside	+